Meme Kanserinde Palyatif Bakım
Özet
Son küresel kanser istatistiklerine göre (2020), meme kanseri (BCa) dünyada en sık teşhis edilen kanser türüdür. Kemoterapi, cerrahi ve radyasyonla birlikte, hem sitotoksik (örn. alkilleyici ajanlar, taksanlar, antimetabolitler ve antrasiklinler), hem hormonal hem de hücre döngüsü inhibitor ajanlarını içeren BCa tedavisinin temel dayanağı olmuştur. BCa patogenezinin karmaşıklığı nedeniyle, birden fazla antikanser ilacı içeren polifarmasi, genellikle mono-kemoterapiden daha yüksek yanıt oranlarına gösterilen bu tedavi yaklaşımının ayrılmaz bir parçası olmaya devam etmektedir .Doksorubicin, siklofosfamid, paklitaksel, dosetaksel, karboplatin, kapesitabin, gemsitabin en sık kullanılan kemoterapötik ajanlar olarak bilinmekte, bunların beraber kullanılması, destek tedavisi ajanları ve CYP enzim sistemi inhibitör. aktivatörleri ile etkileşimde yan etki ve toksisiteler meydana gelebilmektedir.
Referanslar
Dirimen Arıkan, G. (2016). Palyatif Bakım Tanımı ve Felsefesi. Klinik Tıp Aile Hekimliği, 8(3), 1-5.
Dac Teoli; Caroline Schoo; Virginia B. Kalish, Palliative Care, StatPearls Publishing; 2025 Jan.
Quill TE, Abernethy AP. Generalist plus specialist palliative care--creating a more sustainable model. N Engl J Med 2013; 368:1173.
Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26(6):809–815. doi: 10.1158/1055-9965.EPI-16-0889.
Nathan Cherny , Shani Paluch-Shimon 1, Yael Berner-Wygoda Palliative care: needs of advanced breast cancer patients PMCID: PMC6284851 PMID: 30584354
Raskin W, Harle I, Hopman WM, Booth CM. Prognosis, Treatment Benefit and Goals of Care: What do Oncologists Discuss with Patients who have Incurable Cancer? Clin Oncol (R Coll Radiol) 2016;28(3):209–214. doi: 10.1016/j.clon.2015.11.011
Greer JA, Jackson VA, Meier DE Temel JS. Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin. 2013;63(5):349–363. doi: 10.3322/caac.21192
Craig Gouldthorpe 1,2,*, Jenny Power 2,3, Amy Taylor 1,2, Andrew Davies 1,Specialist Palliative Care for Patients with Cancer: More Than End-of-Life Care Cancers (Basel). 2023 Jul 9;15(14):3551. doi: 10.3390/cancers15143551
Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741–749. doi: 10.1001/jama.2009.1198.
Ali SK. Malakouti M: The family meeting. Palliat Support Care. 2015;13(4):1135–1136. doi: 10.1017/S1478951514000984.
BT Li, Wong MH, Pavlakis N. Treatment and prevention of bone metastases from breast cancer: a comprehensive review of evidence for clinical practice. J Clin Med. 2014;3(1):1–24. doi: 10.3390/jcm3010001.
Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592–596
Niravath P. Aromatase inhibitor-induced arthralgia: a review. Ann Oncol. 2013;24(6):1443–1449. doi: 10.1093/annonc/mdt037
Ripamonti CL, Santini D, Maranzano E, Berti M, Roila F, ESMO Guidelines Working Group Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol. 2012;23:vii139–vii154. doi: 10.1093/annonc/mds233
Kloke M, Cherny N. Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2015;26(Suppl 5):v169–v173. doi: 10.1093/annonc/mdv306
Ting Bao, MD Management of Dyspnea in Advanced Cancer: ASCO GuidelineJournal of Clinical Oncology doi.org/10.1200/JCO.20.03465
Mohandas H, Jaganathan SK, Mani MP, Ayyar M, Rohini Thevi GV. Cancer-related fatigue treatment: An overview. J Cancer Res Ther. 2017;13(6):916–929. doi: 10.4103/jcrt.JCRT_50_17.
Bush SH, Lawlor PG, Ryan K, et al. Delirium in adult cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv143–iv165. doi: 10.1093/annonc/mdy147.
Brunault P, Champagne AL, Huguet G. Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients. Psycho-Oncology. 2016;25:513–520. doi: 10.1002/pon.3947
Roth AJ, Massie MJ. Anxiety and its management in advanced cancer. Curr Opin Support Palliat Care. 2007;1(1):50–56. doi: 10.1097/SPC.0b013e32813aeb23
Kennedy Li M, Byrne EN. The Management of Depression in Patients with Cancer. Toronto: Cancer Care Ontario; 2015.
Julie L Ryan 1 Treatment of Chemotherapy-Induced Nausea in Cancer Patients Eur Oncol. 2010;6(2):14–16. doi: 10.17925/eoh.2010.06.02.14
J. Wickham, PhD, RN, AOCN, R. (2017). Managing Constipation in Adults With Cancer. Journal of the Advanced Practitioner in Oncology, 8(2). https://doi.org/10.6004/jadpro.2017.8.2.3
Walling, A. M., Campbell, T., Agarwal, R., Bauer, A., Beck, A. C., Carey, E. C., Case, A. A., Dalal, S., Doberman, D. J., Þ, M., Epstein, A. S., Paul Fairman, N., Fecher, L., Fischer, S., Hong, C., Σ, B., Kapo, J., Kumar, P., Leeper, H., … Sambandam, V. (2025). NCCN Guidelines Version 2.2025 Palliative Care Continue NCCN Guidelines Panel Disclosures. https://www.nccn.org/home/member-
